Pfizer to deCode the genetics of lupus
This article was originally published in Scrip
Executive Summary
Pfizer is to tap into deCode genetics' gene discovery capabilities through a research collaboration that aims to discover sequence variants in the human genome that are associated with specific clinical phenotypes related to systemic lupus erythematosus.